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Abstract
Previous experimental studies to assess the contribution of blood-borne circulating (BBC) cells to
cutaneous wound healing have relied on discontinuous pulsing of labeled BBC elements or bone
marrow transplant protocols. Such approaches do not permit examination of stable BBC cells that
have matured in a physiologically-normal host. We have employed a parabiotic murine model for
cutaneous wound healing to evaluate the relative contribution of stable populations of peripheral
blood cells expressing the green fluorescent protein (GFP) transgene in otherwise normal animals.
Circulating cells (mature and immature) expressing the GFP transgene were easily detected and
quantified in wounds of GFP-negative parabiotic twins during all evaluated stages of the healing
response. Using multiple antibody probes, the relative contribution of various subsets of BBC cells
could be comparatively assessed. In early wounds, some cells expressing mesenchymal epitopes
were documented to be of hematopoietic origin, indicating the utility of this model in assessing
cell plasticity in the context of tissue regeneration and repair. Application of this approach enables
further investigation into the contribution of peripheral blood in normal and abnormal healing
responses.
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Introduction
Wound healing is an intricate, dynamic process that includes inflammatory cells, progenitor
and/or stem cells, soluble mediators (such as transforming growth factor-beta or TGF-β),
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and extracellular matrix (ECM) components (such as collagen and glycosaminoglycans).
Wound healing is classically subdivided into three overlapping phases: inflammation,
proliferation, and remodeling.1,2 It is generally accepted that circulating bone marrow (BM)-
derived leukocytes play a critical role in early wound healing, namely via phagocytosis,
cytokine production, and coordination of other cellular/molecular events essential to the
inflammatory response. Cells that eventually repopulate the wound site have traditionally
been believed to derive primarily from adjacent uninjured tissue.3 These cells include
fibroblasts, endothelial cells (ECs), tissue-derived mononuclear and dendritic cells, and
epithelial cells—mobilized from adjacent mature cells stimulated to divide and migrate, or
from their local progenitors.4 However, recent reports have provided evidence that cells seen
in the peripheral blood (PB), mainly hematopoietic stem cells (HSCs), endothelial
progenitor cells (EPCs), circulating fibrocytes, and BM-derived mesenchymal stem cells
(MSCs), and rare tissue-derived mesenchymal stem cells may also play an important role in
the reconstitution of injured tissue.5-14 Moreover, because skin has recently been shown to
harbor unexpectedly large numbers of resident leukocytes (in human skin, for example,
approximately twice the number of T cells as in the entire circulation15),
immunohistochemical approaches alone fail to reveal whether leukocyte derive from local or
peripheral compartments.
It is thought that adult HSCs and BM-derived MSCs may have some degree of ‘plasticity,’
and thus, under specific situations (such as extensive injury), may have the capacity to
‘transdifferentiate’ into non-lineage cells, including fibroblasts,5 endothelial cells,6 smooth
muscle cells,7 cardiomyocytes,8 hepatocytes,9 and GI tract epithelial cells.10 Like mature
hematopoietic cells (mature HCs), hematopoietic progenitor cells (including EPCs) are also
thought to be recruited to the wound microenvironment soon after injury. Tissue damage
may be responsible for homing of BM-derived stem/progenitor cells to the wound site, and
may also stimulate their differentiation into various solid-organ specific tissues, including
skin.11-14 Reports from studies in cutaneous wound healing suggest that HSCs (and BM-
derived MSCs) have the ability to transdifferentiate into fibroblasts.2,16-18 Moreover, it has
been proposed that circulating fibrocytes are a transitional form in this event.19 In addition,
circulating EPCs are suspected of playing an important role in regenerative responses incited
by tissue ischemia and related cytokine release.16.17.20.21
Thus, skin consists of endogenous epithelial and mesenchymal cellular components as well
as robust populations of resident cells of bone marrow and hematopoietic origin, and blood-
born circulating (heretofore BBC) are composed of both hematopoietic and mobile
mesenchymal stem cells. The ability to investigate roles of mature BBC cells in cutaneous
wound healing requires a model whereby cells in question: (1) circulate as stable
populations within a physiological intravascular microenvironment, (2) infiltrate wounded
tissues devoid of complicating factors (e.g. conditioning regimen), and (3) express
endogenous markers that signify their origin from the intravascular compartment. Existing
models, in which labeled circulating elements are administered via pulsing, produce
transient and potentially unstable conditions, and thus, do not achieve this goal. Moreover,
most transplantation approaches involve hematopoietic reconstitution and require host
irradiation, which may affect relevant microenvironmental factors. In contrast, the parabiotic
model consists of two genetically identical, physiologically-normal mice, surgically
conjoined at the torso, resulting in stable anastomotic linkage between the two peripheral
circulations.22
The parabiotic model employed herein consists of a wild-type mouse (designated GFP-)
conjoined to a transgenic (GFP+) mouse (with somatic cells expressing the gene for green
fluorescent protein, or GFP). After stable chimerization, experimental wounds may be
created, permitting sequential evaluation of the wounds for influx and the potential
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differentiation of any GFP-expressing blood-borne elements.23,24 In this study, we
hypothesize that (1) the parabiotic system is a novel and valuable model for studies of the
contribution of the BBC cell compartment to skin healing and regeneration, and (2) BBC
cells, including those with capacity for transdifferentiation, may be studied by this model in
a manner to assess their participation in the early stages of the healing response. Our data
indicate that BBC cells, including those with capacity for transdifferentiation, actively
participate in the early stages of the healing response, and that this model system is
applicable to further studies of the contribution of the circulating cellular compartment to
skin healing and regeneration.
Materials and Methods
Animal model
All animal procedures were performed in accordance with the Guide for the Care and Use of
Laboratory Animals [National Institute of Health (NIH) publication No. 86-23] and
approved by Brigham & Women's Hospital/Harvard Medical Area Standing Committee on
Animals (IACUC). The generation of parabiotic mice has been described previously by
authors from this study.23 A parabiotic pair consists of an unirradiated (one month-old)
wild-type mouse (C57BL/6 background), surgically conjoined to an age-matched transgenic
GFP+ mouse (C57BL/Ka-EGFP, bred and maintained at the Joslin Diabetic Center) via a
dermal-to-dermal anastomosis at the torso.24 After two weeks with shared circulatory
systems, stable chimerization of a common blood supply (approximately 50% GFP+ and
GFP- nucleated blood cells) was confirmed by flow cytometry, as previously shown.23
Thereafter, identical one cm2 full-thickness wounds (including the panniculus carnosus
muscle) were created on the mid-back of each mouse of the parabiotic pair. Wounds were
covered with transparent, semi-occlusive adhesive dressings (Tegaderm™). Wounds were
then harvested, with early time points selected to maximize evaluation of both mature and
immature hematopoietic cell participation in the early healing response.
Harvesting and processing of tissue specimens
Three and seven days after wounding, five parabiotic pairs (n=10) were sacrificed and
wounds of the wild-type mice were harvested. One pair that remained conjoined was
available for late harvesting (day 21), such that a total of 22 wounds were collectively
evaluated. Adjacent uninjured tissues were also sampled. Once tissue samples were
collected, they were immediately placed in 2% paraformaldehyde (PFH) in 1X Phosphate
Buffer Saline (PBS) solution, where they remained for 4 hours at room temperature (RT).
Subsequently, samples were placed in 10% sucrose in 1X PBS overnight at 4 °C. Specimens
were then placed in optimum cutting temperature (OCT™, Tissue-Tek®) solution and
stored at -25 °C. Frozen tissue blocks were cut at 6-7 μm and serial sections were collected
onto slides for staining.
Immunofluorescence (IF) staining
In preparation for IF staining, slides were thawed to RT. Once dried, slides were fixed in
acetone at -5 °C for 5 minutes. Slides were then rinsed twice (each time for 5 minutes) in
PBS to remove OCT.™ Ten percent donkey serum (in PBS at RT) was added onto samples
(on the slides) and incubated for 30 minutes. Next, primary antibody was added and allowed
to incubate overnight at 4 °C. On the following day, slides were rinsed three times (each
time for 5 minutes) with PBS. Subsequently, secondary antibody was added and allowed to
incubate at RT for 30 minutes (to protect samples from photodamage, incubating apparatus
was wrapped with foil sheets). Slides were then rinsed three more times in the same fashion.
Once dried, 4’,6-diamidino-2-phenylindole (DAPI, nuclear counterstain) solution was
applied and slides were mounted. All slides were also examined using hematoxylin and
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eosin staining by an experienced dermatopathologist in order to define the nuclear
morphology of the infiltrates and to permit their initial classification (bi- or multilobed cells
containing cytoplasmic granules = granulocytes [neutrophils/eosinophils], mononuclear cells
= lymphocytes and monocytes).
Primary antibodies used are as follows—(1) rat monoclonal anti-CD45 (1:10
dilution, BD Pharmingen Inc., San Diego, CA), (2) anti-CD11b (1:200 dilution,
Pharmingen), (3) anti-CD3 (1:50 dilution, Antigenix America Inc., Huntington Station, NY),
(4) anti-collagen I (1:400 dilution, Biogenesis Inc., Kingston, NH), (5) anti-α-smooth muscle
actin (α-SMA, 1:200 dilution, Epitomics Inc., Burlingame, CA), (6) rabbit polyclonal anti-
VE-cadherin/CD144 (1:20 dilution, Cell Signaling Technology Inc., Danvers, MA), (7) anti-
CD31 (1:50 dilution, Pharmingen), (8) anti-CD34 (1:20 dilution, Pharmingen).24 Secondary
antibodies used are as follows: (1) Alexa Fluor 594 donkey anti-rat IgG (1:800 dilution,
Invitrogen Corp., Eugene, OR) for anti-CD45, CD34, CD11b, CD3, and CD31, (2) Alexa
Fluor 594 donkey anti-rabbit IgG (1:800 dilution, Invitrogen) for anti-CD144, collagen type
I, and α-SMA antibodies. Stains for collagen and smooth muscle actin were all run with
appropriate positive and negative tissue controls, as well as isotype-matched irrelevant
controls to exclude non-specific bindings.
Fluorescence microscopy and evaluation of HCs
Slides were examined under fluorescence microscopy (MX51, Olympus Corp., Tokyo,
Japan) with a mercury vapor light source. Photographs of live images at 10X, 40X, 60X
(with oil immersion) were taken with the aid of CytoVision™ 3.7 software (utilizing serial
layer stacking for superior clarity; Applied Imaging Corp., San Jose, CA). Cells were
visualized as follows: nuclei—rendered blue by DAPI counterstain; cells expressing GFP
transgene—green; and specific lineage and non-lineage markers—red by Alexa Fluor 594
fluorochrome. Cells co-expressing GFP and red fluorochrome were identified by (partial to
circumferential) red-to-orange membrane-associated staining surrounding a zone of green
cytoplasm and a variably detectable central blue nucleus.
For quantification of GFP+ cells that express surface markers of interest, at least ten high-
power fields (HPFs) were randomly selected from the central zone of each wound bed
(coagulum excluded). The enumerated cells, based on marker expression plus or minus
associated GFP, were counted only when discrete circumferential membrane staining was
apparent. For accuracy, replicate counts were made for each experimental condition. In a
given field, the total number of cells was tallied for cells with DAPI-positive nuclei (blue).
Cells expressing GFP (in wounds of wild-type parabionts) were taken to represent one-half
of the entire hematopoietic infiltrate, based on known chimerization ratio: total HC
population = 2 × GFP+ cell population. It is worth mentioning at this juncture that although
the aforementioned equation does not encompass the complexity of shared circulation in a
parabiotic pair (since the true total HC population, with respect to GFP+ cell population, is
likely to be multifactorial and presumptively asymptotic), it does however, allow for
calculation of first-order approximation. Accordingly, resident cell (RC) population (non-
hematopoietic, tissue-based) for each field was deduced by the following equation: RC
population = total cell population - (2 × GFP+ cell population). To facilitate analysis, raw
data were normalized, such that total cell population (sum of GFP+ HCs, GFP- HCs, and
GFP- RCs) is set to 100. Numeric values of tabulated subsets of day 3 and day 5 were
averaged and presented as mean ± standard deviation. Ad hoc analysis with associated
probability (p) of 0.05 or less was rendered significant.
Song et al. Page 4














Early stages of wound healing in both wild-type and transgenic parabionts were
characterized by the formation of a fibrin coagulum intimately associated with the wound
bed (Fig. 1a). Both components contained predominantly rounded and occasionally
elongated mononuclear cells at this juncture, without significant accumulation of cells with
bi- or multi-lobed nuclei typical of granulocytes. In addition to demonstrating the efficacy of
the parabiotic model for studies of the initial stages of wound healing, we also sought to test
the model's efficacy for qualitative and quantitative evaluation of BBC cell participation at
early timepoints in the healing response. At both the day 3 and day 7 time points, numerous
GFP+ cells could be detected within both compartments of the wild-type animals (Fig. 1b).
Double labeling permitted lineage determination for both the GFP+ and GFP- compartments
Fig. 1c). This drop-off is verified by H&E stains that reveal parallel decrements in cells with
hematopoietic cytologic features. The ratio of GFP+ versus GFP- cells declined from day 3
to day 7, indicating a more robust hematopoietic infiltrate (> 50% of all nucleated cells) at
the earlier time point [Fig. 1d, Table 1 (due to small sample size, day 21 was excluded from
analysis)]. As compared to control uninjured dermis, hematopoietic cells homed to wound
sites in greater than 5:1 (day 3) and 3.5:1 (day 7) ratios, consistent with the trophic influence
of tissue injury.
With respect to hematopoietic lineage markers, between 31% and 38% of GFP+ BBC cells
infiltrating day 3 wounds co-expressed leukocyte-associated markers CD45, CD11b, and
CD3 (Fig. 2, Table 2). By day 7, only about one-third to one-half of these cells maintained
lineage markers. Regarding non-hematopoietic, mesenchymal marker (collagen I, α-SMA,
and CD144) expression in day 3 wounds, 29-36% of GFP+ cells fit this criteria (Figure 3,
Table 2). A marked decrease in co-expression of these markers was also noted among GFP+
cells by day 7. Nonetheless, at both day 3 and day 7 time points, GFP+ cells were detected in
intimate association with sites of collagen type I reactivity, and individual GFP+ cells were
clearly noted to express α-SMA and CD144 or CD31, consistent with local myofibroblastic
and endothelial differentiation from hematopoietically-derived precursors at the wound site.
These findings were not observed in GFP+ cells that trafficked in non-wounded perilesional
skin of the wild-type parabionts.
Discussion
In this study, a parabiosis model of cutaneous wound healing was employed with the
primary goal of determining the utility of this model in studies designed to examine the
participation of BBC cells in cutaneous wound healing. Our data indicate that the model is
indeed useful, revealing that: (1) infiltrating mature and immature BBM cells are easily
detected and quantified by fluorescent transgene expression in the parabiosis model, (2)
BBC cells predominate over resident skin cells in the early stages of wound healing (day 3),
(3) potential for BBC cell expression of mesenchymal markers exists during this interval.
Parabiotic mice have been used previously to evaluate the migratory fates of BBC cells in
wound healing.23,24 Labeling of BBC cells and their progeny (with a GFP) permitted the
observation that these cells do not contribute substantially to stable chimerization of normal
non-hematopoietic tissues via transdifferentiation.26 Moreover, even in situations where
tissue stress and injury exists, as with myocardial ischemia, resident tissue regeneration from
blood-borne hematopoietic elements does not appear to occur.27 Authentic
transdifferentiation is further complicated by technical difficulties in complex tissues
including possible: (1) cell fusion events, (2) antigen or marker shedding, (3) phagocytosis,
(4) contamination, (5) inductive stimuli for gene expression, and (6) the nature and severity
of tissue injury.28
Song et al. Page 5













However, recent data relating to circulating fibrocytes adds potential credibility to the role
of direct contribution of BBC cells to tissue repair under certain conditions.19,29 These
blood-borne cells express a Col I+/CD11b+/CD13+/CD34+/CD45-RO+/MHC class II+/
CD86+ phenotype and have been shown to rapidly enter sites of tissue injury in a CCR7
chemokine-dependent manner. In vitro, they have the capacity to differentiate into α-SMA+/
TGF-β1-responsive cells contracting fibrin, suggesting a potential role in wound healing and
tissue repair.19
Since the earlier phases of cutaneous wound healing involves inflammation,30 it is not
surprising that a majority of cells infiltrating day 3 wounds are of hematopoietic origin.
While an active acute inflammatory reaction, mediated by neutrophils (as incited classically
by bacterial antigens or foreign material), is generally regarded as counterproductive to
wound healing, the participation of mononuclear cells (monocytes/macrophages and
lymphocytes) is regarded as potentially having a favorable influence, at least indirectly, via
local production of mediators such as platelet-derived growth factor (PDGF) and TGF-β
(both essential stimuli for the subsequent migration and proliferation of resident fibroblasts
and endothelial cells that typifies the proliferative phase).31,32 Because neutrophils were
excluded by conventional histology in the present study, the proportion of total BBC cell
population at day 3 is largely accounted for by undifferentiated leukocytes (CD45) co-
expressing both markers of monocytes (CD11b) and T-lymphocytes (CD3). Interestingly, in
previous studies using rodent models to impede formation of contractile scars—via the use
of biodegradable collagen-glycosaminoglycan (collagen-GAG) matrices—the early
participation of mononuclear cells was one discriminating factor that favored a regenerative
as opposed to a scarring response.33
One noteworthy finding in this study was the extent to which GFP-positive hematopoietic
cells expressed mesenchymal markers (Col I and α-SMA: associated with fibroblasts and
myofibroblasts, respectively; CD144 and CD31: associated with vascular endothelial cells)
in the early wound. While we cannot exclude factors that may mimic or complicate
interpretation of authentic transdifferentiation (as listed above), the robust expression of
these markers by BBC cells (as defined by GFP transgene expression) raises the possibility
that some degree of hematopoietic plasticity may manifest in the early stages of cutaneous
wound healing. Future studies are now possible using a variety of technologies, including in
situ hybridization and laser capture microdissection coupled with real time RT-PCR
analysis, in order to better define transdifferentiation of BBC cells in healing wounds at gene
expression levels. Interestingly, because these markers significantly dissipate, along with
relative hematopoietic contribution, by day 7, the expression of mesenchymal epitopes could
easily be overlooked unless very early time points are examined. The question of whether
transdifferentiation of hematopoietic elements occurs during early wound healing cannot be
resolved definitively based upon the present study. However, the parabiosis model should
provide a useful, and potentially powerful, model for studies examining this possibility
further.
The rapid dissipation of hematopoietic elements and related hematopoietic and
mesenchymal markers, subsequent to day 3, suggests that these cells are not directly or
permanently incorporated into new tissue during wound healing. The loss of GFP-positive
cells may be the result of apoptosis34 or simply the kinetics within the proliferative phase,
whereby resident skin cells encroach upon and dominate the nucleated constituents of the
repair process. The possibility of some degree of degeneration and cell death of
hematopoietic elements is potentially supported by the observation of an attendant decrease
in lineage marker expression by GFP-positive cells over time—possibly the result of
biosynthetic impairment. The consequential implication is that participants that restore
fibroblast/myofibroblast and endothelial cell population in dermal wounds in
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physiologically-normal hosts are primarily derived from local, nonhematopoietic
subpopulations. Nonetheless, the finding of a robust and potentially plastic hematopoietic
response raises the possibility that strategies could be devised to experimentally or
therapeutically manipulate hematopoietic cells during early stages of skin repair in a manner
that promotes their potential contribution to accelerated healing or even regeneration.
In conclusion, we have preliminarily evaluated a parabiosis model for experimental study of
hematopoietic contribution to cutaneous wound healing. Our data support the applicability
and utility of this novel approach and indicate that an early and brisk BBC cell response,
mediated by mononuclear cells with transdifferentiation potential, typifies early stages of
skin repair. Further studies are now possible using parabiosis models to more precisely
define the molecular and cellular mechanisms whereby hematopoietic cells contribute to
normal and pathologic healing responses.
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Evaluation of day 3 wound in wild-type parabiont by (a) light microscopy, (b and c)
fluorescent microscopy, and (d) graphic representation showing relative subpopulations of
hematopoietic cells and resident cells. Note the numerous GFP+ cells infiltrating the wound
bed (B) and associated fibrin coagulum (F) (panel b). Application of lineage markers (here
depicted CD144) permits discrimination of four cell types: 1) CD144+, non-hematopoietic
(resident) cell; 2) CD144+, hematopoietically-derived cell; 3) CD144- hematopoietically-
derived cell; and 4) CD144-, non-hematopoietic (resident) cell. The graphic representation
(d) of relative numbers of hematopoietic versus resident cells suggests a marked
contribution of the former at day 3 (as compared to uninjured dermis at day 3), followed by
a decline by day 7.
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Expression of hematopoietic lineage markers CD45 (leukocytes), CD11b (monocytes), and
CD3 (T-cells) in day 3 wounds. Small panels at top left depict GFP+ and GFP- cells, while
small panels at bottom left indicate respective lineage marker positive and negative
populations in same field. The larger panel to the right shows a merged image with thick
arrows indicating GFP+/lineage marker(+) cells (hematopoietically-derived from transgenic
parabiont), and thin arrows indicating GFP-/lineage marker(+) cells (either
hematopoietically or locally derived from wild-type parabiont). All scale bars = 10 μm.
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Documentation of mesenchymal lineage marker expression in wounds at days 3 and 7. At
both time points, GFP+ cells are focally associated with these markers (arrows indicate
GFP+ cells co-expressing respective markers). By day 7, some GFP+ cells that retain the
lineage markers appear to be more elongated, and cells expressing CD144 and CD31 are
focally associated with arcuate and rounded structures with lumen-like centers (L)
resembling forming blood vessels.
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Table 1
Relative Percentages of GFP+ cell, Total Hematopoietic Cell (HC), and Resident Cell (RC) Subpopulations at
Day 3 and Day 7 (as well as adjacent uninjured dermis) (p <0.01)
Day 3 (n=5) Day 7 (n=5) Adjacent uninjured dermis (n=10)
GFP+ Cells 29% ± 1% 19% ± 1% 4% ± 1%
Total Hematopoietic Cells (HCs, 2 × GFP+ Cells) 57% ± 2% 38% ± 1% 9% ± 1%
Resident Cells (RCs) 43% ± 2% 62% ± 1% 91% ± 1%
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Table 2
Percent of GFP+ Cells Co-expressing Hematopoietic Lineage and Non-lineage Markers at Day 3 and Day 7 (p
<0.01)
GFP+ Cells Day 3 (n=5) GFP+ Cells Day 7 (n=5)
CD45 (all leukocytes, lineage) 34% ± 3% 23% ± 2%
CD11b (monocytes/macrophage, lineage) 38% ± 3% 14% ± 2%
CD3 (T-cells, lineage) 31% ± 5% 10% ± 4%
Collagen I (fibroblasts, non-lineage) 36% ± 5% 10% ± 3%
α-SMA (myofibroblasts, non-lineage) 33% ± 4% 19% ± 3%
CD144 (vascular endothelial cells, non-lineage) 29% ± 2% 13% ± 2%
CD31** (vascular endothelial cells) 30% ± 4% 13% ± 1%
CD34** (vascular endothelial cells) 27% ± 2% 14% ± 1%
**
CD31 and CD34 are not non-lineage markers, but are used in conjunction with CD144 to confirm endovascular presence—see Materials and
Methods
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